Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Dose Heparin in Off-pump Coronary Artery Bypass
NCT02812355Phase 4Unknown
- Sponsor
- ASST Lecco
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, single-blind trial of heparin in ischemic heart disease (IHD) (2 arms), sponsored by ASST Lecco. Primary endpoints: Composite vascular complications at 30 days and Composite major bleeding events at 48 hours. Status: unknown.
02
Drugs
heparin
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT02812355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812355.